NewEdge Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55K | Buy |
26,569
+19
| +0.1% | +$39 | ﹤0.01% | 2637 |
|
|
2025
Q1 | $58.4K | Hold |
26,550
| – | – | ﹤0.01% | 2495 |
|
|
2024
Q4 | $40.6K | Hold |
26,550
| – | – | ﹤0.01% | 2587 |
|
|
2024
Q3 | $52.8K | Buy |
+26,550
| New | +$52.8K | ﹤0.01% | 2413 |
|
|
2023
Q4 | – | Sell |
-2,800
| Closed | -$2.88K | – | 3811 |
|
|
2023
Q3 | $2.88K | Hold |
2,800
| – | – | ﹤0.01% | 2967 |
|
|
2023
Q2 | $3.25K | Hold |
2,800
| – | – | ﹤0.01% | 2954 |
|
|
2023
Q1 | $4.23K | Buy |
2,800
+1,400
| +100% | +$2.11K | ﹤0.01% | 2837 |
|
|
2022
Q4 | $4 | Buy |
+1,400
| New | +$4 | ﹤0.01% | 3844 |
|